6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil has been researched along with e-ebu-dm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; De Clercq, E; Inouye, N; Miyasaka, T; Sekiya, K; Shigeta, S; Takashima, H; Tanaka, H; Ubasawa, M; Walker, RT | 1 |
| Chrétien, JR; Grierson, DS; Kireev, DB; Monneret, C | 1 |
| Andreola, ML; Aubertin, AM; Bisagni, E; Dollé, V; Kirn, A; Legraverend, M; Nguyen, CH; Tarrago-Litvak, L; Ventura, M | 1 |
3 other study(ies) available for 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil and e-ebu-dm
| Article | Year |
|---|---|
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Thymine | 1995 |
A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
Topics: Anti-HIV Agents; Drug Design; HIV Reverse Transcriptase; HIV-1; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thymine | 1997 |
Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line; Cells, Cultured; Drug Resistance, Microbial; HIV-1; Humans; Pyridones; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Virion; Virus Replication | 2000 |